1. Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, The University of Sydney, Sydney, New South Wales 2006, Australia
2. School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
3. Division of Cyclotron and Allied Radiopharmaceutics, INMOL Cancer Hospital, New Campus Road, Lahore 54600, Pakistan
4. Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan